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ABSTRACT The Gram-negative opportunistic pathogen Pseudomonas aeruginosa
has distinct genetic programs that favor either acute or chronic virulence gene ex-
pression. Acute virulence is associated with twitching and swimming motility, ex-
pression of a type III secretion system (T3SS), and the absence of alginate, Psl, or Pel
polysaccharide production. Traits associated with chronic infection include growth as
a biofilm, reduced motility, and expression of a type VI secretion system (T6SS). The
Rsm posttranscriptional regulatory system plays important roles in the inverse con-
trol of phenotypes associated with acute and chronic virulence. RsmA and RsmF are
RNA-binding proteins that interact with target mRNAs to control gene expression at
the posttranscriptional level. Previous work found that RsmA activity is controlled by
at least three small, noncoding regulatory RNAs (RsmW, RsmY, and RsmZ). In this
study, we took an in silico approach to identify additional small RNAs (sRNAs) that
might function in the sequestration of RsmA and/or RsmF (RsmA/RsmF) and identi-
fied RsmV, a 192-nucleotide (nt) transcript with four predicted RsmA/RsmF consen-
sus binding sites. RsmV is capable of sequestering RsmA and RsmF in vivo to acti-
vate translation of tssA1, a component of the T6SS, and to inhibit T3SS gene
expression. Each of the predicted RsmA/RsmF consensus binding sites contributes to
RsmV activity. Electrophoretic mobility shifts assays show that RsmF binds RsmV
with 10-fold higher affinity than RsmY and RsmZ. Gene expression studies revealed
that the temporal expression pattern of RsmV differs from those of RsmW, RsmY,
and RsmZ. These findings suggest that each sRNA may play a distinct role in con-
trolling RsmA and RsmF activity.
IMPORTANCE The members of the CsrA/RsmA family of RNA-binding proteins play
important roles in posttranscriptional control of gene expression. The activity of
CsrA/RsmA proteins is controlled by small noncoding RNAs that function as decoys
to sequester CsrA/RsmA from target mRNAs. Pseudomonas aeruginosa has two CsrA
family proteins (RsmA and RsmF) and at least four sequestering sRNAs (RsmV [identi-
fied in this study], RsmW, RsmY, and RsmZ) that control RsmA/RsmF activity. RsmY
and RsmZ are the primary sRNAs that sequester RsmA/RsmF, and RsmV and RsmW
appear to play smaller roles. Differences in the temporal and absolute expression
levels of the sRNAs and in their binding affinities for RsmA/RsmF may provide a
mechanism of fine-tuning the output of the Rsm system in response to environmen-
tal cues.
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Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen that can causeacute infections in the immunocompromised and chronic infections in individuals
with cystic fibrosis (CF) (1, 2). Acute P. aeruginosa maladies include skin and soft tissue 
infections, ventilator-associated pneumonia (VAP), and urinary tract infections. P. 
aeruginosa bacteria isolated from acute infections are typically motile, nonmucoid, and 
toxigenic. Acute infections by multidrug-resistant P. aeruginosa are difficult to resolve 
and can progress to sepsis resulting in a high rate of morbidity and mortality (3). 
Chronic P. aeruginosa infections are most common in CF patients and result from a 
variety of mutations in the CF transmembrane conductance regulator (CFTR) ion 
channel. The clearance defect in CF results from dehydrated and thickened mucus and 
from physiochemical changes in the airway surface fluid (4). The persistence of P. 
aeruginosa in the CF airways is associated with adaptive changes, including loss of 
motility, growth as a biofilm, mucoidy, and loss of some acute virulence functions (5, 6). 
The coordinate transition from an acute to a chronic infection phenotype is regulated 
by a variety of global regulatory networks, including the Rsm system (7).
The Rsm system controls 10% of the P. aeruginosa genome, including type III 
secretion (T3S) and type VI secretion (T6S), exopolysaccharides important for biofilm 
formation, and motility (8, 9). The Rsm system includes two small RNA-binding proteins 
(RsmA and RsmF/RsmN [RsmA and RsmF]) and at least three small noncoding RNAs 
(RsmW, RsmY, and RsmZ) that function by sequestering RsmA and RsmF from mRNA 
targets. RsmA and RsmF are part of the CsrA family and regulate gene expression at the 
posttranscriptional level. RsmA and RsmF are 31% identical at the amino acid level, and 
both rely on a conserved arginine residue for RNA-binding activity (10, 11). RsmA and 
RsmF directly interact with mRNA targets to positively or negatively alter translation 
efficiency and/or mRNA stability (8, 12, 13). The RsmA and RsmF binding sites on target 
mRNAs commonly overlap the ribosome binding site and consist of a conserved 
5=-CANGGAYG sequence motif (where N is any nucleotide, the underlined GGA is 100%
conserved, and Y is either a cytosine or uracil) that presents the GGA sequence in the 
loop portion of a stem-loop structure (10, 14–16). While RsmA is able to bind mRNA 
targets with a single CANGGAYG sequence (14), RsmF differs in that high-affinity 
binding is observed with mRNA targets possessing at least two CANGGAYG consensus 
binding sites (14). Although RsmA and RsmF have some targets in common, the full 
extent of the regulons is unknown (10, 11). The RsmF regulon, however, was recently 
determined using a pulldown method to identify 503 target RNAs (17).
The RNA-binding activity of RsmA is controlled by the small noncoding RNAs RsmW, 
RsmY, and RsmZ (10, 18). RsmW, RsmY, and RsmZ each have multiple CANGGAYG 
binding sites that allow sequestration of RsmA from target mRNAs (19). It is unclear 
whether RsmW, RsmY, and RsmZ are the only small RNAs (sRNAs) that function in the 
sequestration of RsmA or whether RsmW, RsmY, or RsmZ are the primary sRNAs that 
function in sequestration of RsmF. The affinity of RsmF for RsmY and RsmZ is 10-fold 
lower than that of RsmA. In this study, we sought to identify additional sRNAs that 
regulate RsmA and RsmF activity and identified RsmV, a 192-nucleotide (nt) transcript 
that has four CANGGAYG sequences presented in stem-loop structures. We demon-
strate that RsmV is able to sequester RsmA and RsmF in vivo, that full RsmV activity is 
dependent upon each of the four CANGGAYG sequences, and that RsmV demonstrates 
a temporal expression pattern that is distinct from those seen with RsmW, RsmY, and 
RsmZ. We propose a model wherein each sRNA plays differential and distinct roles in 
control of the Rsm system.
RESULTS
Identification of RsmV as a sequestering RNA for RsmA and RsmF. We took an 
in silico approach to identify candidate sRNAs that might control RsmA activity 
and/or RsmF activity in vivo. A prior SELEX (systematic evolution of ligands) study 
concluded that optimal RNA-binding activity by RsmF requires RNA targets with at 
least two GGA sequences presented in the loop portion of stem-loop structures. 
Transcriptome sequencing (RNA-seq) studies have identified 500 potential sRNAs
in P. aeruginosa (20, 21). The secondary structure of each sRNA was predicted using 
mFold and then examined for the presence of 2 GGA sequences presented in 
stem-loop structures. One sRNA candidate had six GGA sequences (Fig. 1A). Each 
GGA sequence demonstrated a 60% match to the full RsmA/RsmF consensus 
binding site (CAnGGAyG) (Fig. 1B). Four of the GGA sequences (designated sites 2, 3, 
5, and 6) are predicted by mFold to be presented in stem-loop structures (Fig. 1A). 
The gene encoding the sRNA is located in the intergenic region between mucE and 
apqZ and has been designated rsmV (Fig. 1C). A search of the Pseudomonas 
Genome Database indicated that the rsmV sequence is highly conserved in 100 
sequenced P. aeruginosa genomes and is absent from the genomes of other 
pseudomonads.
The RNA-seq study that identified rsmV concluded that the RNA is 192 nucleotides 
(nt) long (21). To verify the rsmV transcription start site, cDNA was generated using a 
primer within the gene (Fig. 1D). The cDNA was then used in a PCR with primers 
positioned just upstream of and at the predicted start site. Whereas the primer 
positioned at the start site generated the expected product, the primer located just 
upstream did not generate a product. This finding is consistent with the rsmV tran-
scription start site identified in the Wurtzel RNA-seq study (21). There is no identifiable 
transcriptional terminator downstream of rsmV. To verify the 3= boundary, cDNA was 
generated from total cellular RNA with primers positioned at the predicted 3= end of 
rsmV and at several downstream positions as shown in Fig. 1C. The resulting cDNAs 
were then used as templates in PCRs with primers (Fprimer and Rprimer) positioned 
within the gene (Fig. 1C). The cDNA primer positioned within the aqpZ coding region 
(primer 4) did not yield a product. The cDNA primers positioned upstream of aqpZ 
(primers 1, 2, and 3) all yielded products, and the strongest product was observed with 
cDNA generated at the predicted 3= terminus of rsmV using primer 2 (Fig. 1E). The 
weaker PCR products produced from cDNA generated with primers 2 and 3 may 
represent transcriptional readthrough.
RsmV interacts with and controls RsmA and RsmF activity. The presence of four 
predicted GGA sequences in stem-loop structures is consistent with RsmV serving as a 
sequestering sRNA for RsmA and/or RsmF. To test this prediction, we measured binding 
using electrophoretic mobility shift assays (EMSAs). Full-length RsmV was synthesized 
in vitro, radiolabeled at the 5= end, and incubated with purified RsmAHis or RsmFHis prior 
to electrophoresis on nondenaturing gels. RsmAHis formed high-affinity binding prod-
ucts with RsmV (equilibrium constant [Keq]  14 nM), and two distinct binding 
complexes were evident (Fig. 2A). Those products could reflect binding of multiple 
RsmAHis dimers or differential interactions with multiple sites on the RsmV probe. RsmF 
also bound the RsmV probe with high affinity (Keq  2 nM), but only a single binding 
complex was detected (Fig. 2A).
With evidence indicating that both RsmA and RsmF interact with RsmV, we next 
examined whether RsmV can sequester RsmA/RsmF in vivo. RsmA and RsmF have 
inverse effects on expression of the type VI secretion system (T6SS) and the type III 
secretion system (T3SS) (10). We used the previously described Plac-tssA1=-=lacZ transla-
tional reporter as a surrogate for regulatory control of the T6SS (10) and the PexsD-lacZ 
transcriptional reporter as a marker for the T3SS (22). RsmA/RsmF directly bind the tssA1 
leader region to inhibit translation (10, 14) and positively regulate T3SS gene expression 
through a mechanism that remains to be defined (10). In a mutant lacking rsmV, rsmY, 
and rsmZ, RsmA/RsmF availability is high, resulting in repression of Plac-tssA1=-=lacZ 
reporter activity and high levels of PexsD-lacZ reporter activity (Fig. 2B and C). The 
presence of plasmid-expressed RsmV resulted in significant activation of Plac-tssA1=-=lacZ 
reporter activity and inhibition of the PexsD-lacZ reporter. Both of these findings are 
consistent with RsmV serving a role in RsmA/RsmF sequestration. Compared to the 
previously identified sequestering RNAs RsmW, RsmY, and RsmZ (10, 23), RsmV dem-
onstrated activity comparable to RsmY in experiments using the Plac-tssA1=-=lacZ reporter
FIG 1 Predicted structure of RsmV and genomic context. (A) Predicted mFold structure of RsmV. The P. 
aeruginosa RsmV secondary structure was determined by mFold modeling. Each of the six GGA sequences is 
highlighted in red and numbered by order of appearance from the 5= end of the sequence. (B) Alignment of each 
GGA site to the full RsmA/RsmF consensus binding site. The GGA sites are 100% conserved (red), and other 
conserved portions of the consensus sequence are highlighted in blue. (C) The genome context of rsmV, located 
between mucE and aqpZ. The positions of the primers used to generate cDNA for the experiment represented 
in Fig. 2B are labeled 1 to 4. The primers used to generate PCR products in Fig. 2B are labeled Fprimer and 
Rprimer. (D and E) Verification of the rsmV 5= and 3= boundaries. (D) RNA purified from wt cells was used to 
generate cDNA using the indicated 3= primer. The cDNA was then used in PCRs with the same 3= primer and 5= 
primers positioned just upstream of or at the predicted start of rsmV transcription. Genomic DNA (gDNA) served 
as a positive control. N/A, not applicable. (E) Verification of the rsmV termination site. cDNA was generated using 
primers 1 to 4 as shown in panel C. The cDNA was then used in PCRs with the primer sets indicated in panel C. 
Genomic DNA (gDNA) served as a positive control.
FIG 2 RsmV binding and regulatory activity. (A) RsmV was radiolabeled and used in electrophoretic 
mobility shift assays with purified RsmA (lanes 2 to 5) and RsmF (lanes 7 to 10) at the indicated 
concentrations. The position of the unbound RsmV probe is indicated. (B and C) Effect of RsmV on 
Plac-tssA1=-=lacZ (PtssA1=-=lacZ) translational reporter (B) and PexsD-lacZ transcriptional reporter (C) activities. 
Strains consisting of a ΔrsmVYZ mutant transformed with either a vector control (pJN105) or the 
indicated sRNA expression plasmids were cultured in the presence of 0.4% arabinose to induce 
expression of the respective RNAs and were assayed for -galactosidase activity. The reported values 
represent the averages of results from at least three experiments, with the standard error indicated. *, P 
value of 0.05; **, P value of 0.01 (relative to the vector control data).
(Fig. 2B) and had strong inhibitory activity with respect to the PexsD-lacZ reporter
(Fig. 2C).
To determine whether RsmV preferentially sequesters either RsmA or RsmF, the
Plac-tssA1=-=lacZ translational reporter was introduced into rsmAVYZ and rsmFVYZ 
mutant backgrounds. RsmA is more active than RsmF, resulting in stronger repression
of Plac-tssA1=-=lacZ reporter activity in the ΔrsmFVYZ mutant than in the ΔrsmAVYZ
background for strains carrying the vector control (pJN105) (Fig. 3A versus B). In the
ΔrsmFVYZ mutant, where repression of Plac-tssA1=-=lacZ activity is attributable to RsmA, RsmV 
demonstrated relatively weak suppressive activity compared to RsmW, RsmY, and RsmZ
(Fig. 3A). A similar picture emerged in experiments using the ΔrsmAVYZ background to 
examine RsmF sequestration in that RsmV demonstrated the weakest suppressive activity
(Fig. 3B). Thus, RsmV is capable of sequestering both RsmA and RsmF but appears to lack 
a strong preference for one versus the other under the conditions tested.
Contribution of GGA sites 2, 3, 5, and 6 to RsmV activity. The RsmV primary
sequence contains six GGA sequences, four of which (GGA2, GGA3, GGA5, and GGA6)
may be presented in the loop portions of stem-loop structures (Fig. 1A). To determine
which GGA sites are important for RsmV regulatory activity, each of the GGA sequences 
in stem-loop structures was changed to CCU. mFold predictions of the single GGA
FIG 3 Sequestration of RsmA or RsmF by the RsmV, RsmW, RsmY, and RsmZ regulatory RNAs. Either 
ΔrsmAVYZ (A) or ΔrsmFVYZ (B) quadruple mutants carrying the Plac-tssA1=-=lacZ (PtssA1=-=lacZ) translational 
reporter were transformed with either a vector control (pJN105) or RsmV, RsmW, RsmY, and RsmZ 
expression plasmids. The resulting strains were cultured in the presence of 0.4% arabinose to induce 
expression of the respective RNAs and assayed for -galactosidase activity. Reported values represent 
averages of results from at least three experiments, with the standard error indicated. *, P value of 0.05 
relative to the vector control.
mutants indicated that each is expected to adopt the same secondary structure shown 
in Fig. 1A for wild-type (wt) RsmV. The activity of each mutant RNA was tested using the 
Plac-tssA1=-=lacZ translational and PexsD-lacZ transcriptional reporters. The GGA3 and GGA6 
mutant RNAs demonstrated a significant loss of regulatory activity for the Plac-tssA1=-=lacZ 
translational reporter compared to wt RsmV (Fig. 4A). In contrast, each of the GGA sites 
was required for full regulatory control of the PexsD-lacZ transcriptional reporter (Fig. 4B). 
Differences in the activities of the mutant RNAs were not attributable to altered RNA 
stability as determined by quantitative reverse transcription-PCR (qRT-PCR) (Fig. 4C). 
The most likely explanation for the differential requirement for the GGA2 and GGA5 
sites is that the PexsD-lacZ reporter is more sensitive to changes in RsmA availability than 
the Plac-tssA1=-=lacZ reporter.
The simplest interpretation of the reporter findings is that the mutant RNAs with 
altered activity have a reduced capacity to sequester RsmA/RsmF. To test this predic-
tion, binding assays were performed with radiolabeled RNA probes. RsmA bound each 
of the single GGA substitution mutants with affinities similar to or greater than those 
seen with wt RsmV (Fig. 4D and Table 1) (see also Fig. S1 in the supplemental material). 
We consistently observed two distinct products upon RsmA binding to the wt, GGA2, 
and GGA5 probes. Only a single product was observed for the GGA3 and GGA6 probes. 
This is noteworthy, as the mutant GGA3 and GGA6 RNAs also demonstrated a defect in 
activation of the Plac-tssA1=-=lacZ translational reporter (Fig. 4A). RsmF also bound each of 
the mutant probes with high affinity, with the exception of GGA6, where binding 
affinity was significantly reduced (Fig. 4E and Table 1; see also Fig. S1). Given that RsmA 
and RsmF are homodimers with two RNA binding sites (one from each monomer) and 
that each mutant RNA still has three potential GGA interaction sites, high-affinity 
binding to the mutant probes was not unexpected. We thus generated a probe bearing 
CCU substitutions at all four sites (Quad) and found that RsmA (Keq, 27 nM) and RsmF 
(Keq, 243 nM) were unable to bind (Fig. 4D and E and Table 1; see also Fig. S1) or exert 
regulatory control over the Plac-tssA1=-=lacZ translational and PexsD-lacZ transcriptional 
reporters. We conclude that the primary sites for RsmA/RsmF binding are GGA2, GGA3, 
GGA5, and GGA6.
FIG 4 Functional analyses of the RsmV mutants. (A and B) The PA103 ΔrsmVYZ mutant carrying the 
Plac-tssA1=-=lacZ (PtssA1=-=lacZ) translational reporter (A) or PexsD-lacZ transcriptional reporter (B) was transformed 
with either a vector control (V) (pJN105) or the indicated RsmV expression plasmids. The resulting strains 
were cultured in the presence of 0.4% arabinose to induce expression of the respective RNAs and assayed 
for -galactosidase activity. Reported values represent averages of results from at least three experi-
ments, with the standard error indicated. *, P value of 0.05 relative to cells expressing wt RsmV. (C) RNA 
levels of native RsmV and the indicated GGA mutants were determined by qRT-PCR. Each RNA sample 
was normalized to rimM. The reported values represent averages of results from three experiments. (D 
and E) EMSAs with wt RsmV and the indicated mutant radiolabeled probes. A 40 nM concentration of 
RsmA (D) or RsmF (E) was incubated with the indicated probes, and the reaction mixture was subjected 
to nondenaturing gel electrophoresis and phosphorimaging. The positions of the unbound probes are 
indicated.
Role of RsmV in vivo. Data presented thus far have relied upon plasmid-expressed
RsmV, the expression of which may result in RNA levels that exceed the native level
expressed by cells under physiologically relevant conditions. To address the effect of RsmV
expressed at native levels on the output of the Rsm system, we generated an in-frame rsmV
deletion mutant (ΔrsmV) and measured PexsD-lacZ reporter activity. Compared to wt cells, the
ΔrsmV mutant cells demonstrated a modest but significant increase in reporter activity (Fig.
5A). This increase in reporter activity is consistent with reduced sequestration of RsmA and
RsmF, both of which have a positive effect on T3SS gene expression. By comparison,
PexsD-lacZ reporter activity was also elevated in an ΔrsmYZ double mutant.
A second approach to test the relevance of RsmV in vivo involved precipitation
experiments with histidine-tagged RsmA or RsmF. A ΔrsmAF double mutant trans-
formed with either RsmAHis or RsmFHis expression plasmids was cultured to mid-log
phase and then rapidly subjected to precipitation with Ni2-agarose beads and isola-
tion of bound RNA. The presence of specific RNAs was detected from the entire pool
of bound RNAs by qRT-PCR. The positive controls were the known RsmA/RsmF targets
RsmY and RsmZ and the tssA1 leader region (10). Negative controls included (i) two
mRNAs (lolB and rnpB) that are not known targets of RsmA or RsmF and (ii) Ni2-
agarose beads alone. Whereas no enrichment of the lolB or rnpB mRNAs was detected,




wt RsmV 14  4a 2  0.2
GGA2 3  3 1  0.6
GGA3 1  0.4 5  3
GGA5 3  3 8  13
GGA6 9  11 243
Quad 27 243
aThe indicated value represents the apparent equilibrium binding constant.
FIG 5 In vivo activity of RsmV. (A) Strain PA103 (wt) and the ΔrsmV and ΔrsmYZ mutants carrying the 
PexsD-lacZ transcriptional reporter were cultured under inducing conditions for T3SS gene expression and 
assayed for -galactosidase activity. *, P value of 0.05 relative to wt. (B) A ΔrsmAF mutant transformed 
with either a vector control or pRsmAHis or pRsmFHis expression vectors was cultured and subjected to 
rapid purification of pRsmAHis or pRsmFHis and bound RNAs. Select RNAs (as indicated) were quantified 
from the purified RNA pool by qRT-PCR and are reported as fold change relative to the vector control. 
The coding sequences for lolB and rnpB were included as negative controls, and tssA1 served as a positive 
control. Reported values represent averages of results from at least three replicates, with the standard 
error reported. *, P value of 0.05 (compared to expression of the wild-type vector).
FIG 6 Expression profiles of RsmV, RsmW, RsmY, and RsmZ shown by a growth curve analysis. RNA was 
isolated from wt cells harvested at the indicated A600 readings and used as the template in RT-qPCR 
experiments with primers specific to rsmV, rsmW, rsmY, and rsmZ. Each RNA sample was normalized to 
rimM. The values for each RNA are reported relative to the measurement of the sample collected at an 
A600 of 0.5. The data represent averages of results from at least three replicates.
there was significant enrichment of the tssA1 mRNA and of the RsmV, RsmY, and RsmZ 
sRNAs by both RsmA and RsmF (Fig. 5B).
Differential expression of RsmV, RsmW, RsmY, and RsmZ. The in vivo data 
demonstrate that RsmV, RsmW, RsmY, and RsmZ are each capable of sequestering 
RsmA and RsmF. We hypothesized that differential expression of the RNAs might 
allow cells to fine-tune the output of the Rsm system. To test for differential 
expression, RNA samples were collected from cells cultured at optical densities at 
600 nm (OD600) of 0.5 (mid-log phase), 1.0 (late log phase), and 2.0, 5.0, and 7.0 (late 
stationary phase) and readings were performed. The amount of each RNA detected
by qRT-PCR at each growth phase was normalized to cells harvested at an OD600 of 
0.5, and the values for each subsequent time point are reported relative to those 
values (Fig. 6). Both RsmY and RsmZ showed a transient increase in expression at 
late-log phase, followed by a decrease at OD600 of 2.0 and 5.0, and then a significant 
increase in late stationary phase (OD600 of 7.0). Expression for RsmW was delayed 
until the OD600 reached 2.0, but the highest fold changes in expression were 
demonstrated at OD600 values of 2.0 and 5.0 and then approached the fold changes 
observed for RsmY and RsmZ at an OD600 of 7.0. In contrast, RsmV demonstrated a 
slow but steady increase in expression throughout the growth curve but was the 
least dynamic of the four RNAs. The observed differences in expression patterns are 
consistent with the hypothesis that the sRNAs may serve distinct roles in RsmA/
RsmF sequestration on the basis of their timing of expression.
One mechanism to account for the differential expression of RsmV, RsmW, RsmY, 
and RsmZ is transcriptional control by distinct transcription factors. Transcription of 
rsmY and rsmZ is controlled by the GacAS two-component system (24). A previous 
study found that GacAS does not control rsmW transcription (23). To determine 
whether rsmV transcription is regulated by GacA, a PrsmV-lacZ transcriptional reporter 
was integrated at theCTX phage attachment site of wt cells and a ΔgacA mutant. 
Whereas PrsmY-lacZ and PrsmZ-lacZ reporter activity demonstrated strong gacA depen-
dence, PrsmV-lacZ activity showed no difference between the wild-type strain and the 
gacA mutant (Fig. S2).
DISCUSSION
The primary RsmA/RsmF-sequestering RNAs in Pseudomonas aeruginosa are RsmY 
and RsmZ. In addition to RsmY/RsmZ, RsmW plays a smaller role in the sequestration 
of RsmA (23) and can also sequester RsmF (Fig. 3). RsmV represents a fourth RsmA/
RsmF-sequestering RNA in P. aeruginosa. RsmV shares sequence and structural charac-
teristics with RsmY and RsmZ, including multiple GGA motifs (6), four of which are likely 
presented in stem-loop structures. RsmY and RsmZ are also the primary sequestering 
RNAs in P. fluorescens (now P. protegens) (18). At least one additional sRNA, RsmX, also 
contributes to Rsm control in P. protegens (25). The involvement of multiple seques-
tering sRNAs in the control of CsrA/RsmA activity is common. CsrB is the primary 
CsrA-sequestering RNA in Escherichia coli and contains 18 GGA motifs (26). Other E. coli 
sRNAs can also sequester CsrA, including CsrC and McaS (27, 28). CsrC has a structure 
similar to that of CsrB but with fewer GGA motifs (27). McaS is an sRNA that shows base 
pairing with some mRNAs involved in curli and flagellum synthesis and can also 
sequester CsrA via two GGA motifs (28). In addition to sRNAs, the 5= untranslated region 
of mRNAs can also function in the sequestration of CsrA (29).
The activities of RsmV, RsmW, RsmY, and RsmZ were compared by expressing 
each sRNA from an arabinose-inducible expression vector. Plasmid-expressed RsmV 
activated Plac-tssA1=-=lacZ reporter activity and inhibited PexsD-lacZ reporter activity (Fig. 
3B and C). RsmV had activity comparable to that shown by RsmY for activation of 
the Plac-tssA1=-=lacZ reporter activity and a strong effect on activation of PexsD-lacZ 
reporter activity. RsmA and RsmF both bind to RsmV with high affinity in vitro (Fig. 
2A), and the affinity of RsmF for RsmV is at least 10-fold higher than for RsmY and 
RsmZ (10, 14). Although the affinity of RsmF for RsmV is higher in vitro, RsmV does 
not seem to show preferential activity toward RsmF over RsmA in vivo (Fig. 3). The 
reason for this is unclear but may reflect differences between the in vitro and in vivo 
binding conditions. A difference between the results seen under in vitro and in vivo 
conditions was also evident in examination of the RsmV GGA mutants. Whereas 
each of single GGA substitution mutants demonstrated altered regulatory control of 
PexsD-lacZ and/or Plac-tssA1=-=lacZ reporter activity (Fig. 4A and B), the binding affinity 
of RsmA and RsmF was relatively unaffected by the single GGA substitutions (Table 
1). A similar trend was observed in a previous mutagenesis study of RsmY and RsmZ 
wherein the in vivo activity did not strictly correlate with in vitro binding (30). It was 
speculated that other RNA binding proteins, such as Hfq, may prevent binding to 
suboptimal sites in vivo.
RsmV activity was clearly evident when it was expressed from a plasmid (Fig. 2). A 
role for RsmV when expressed at native levels from the chromosome was also detected. 
Deletion of rsmV resulted in a modest but significant increase in T3SS reporter activity 
(Fig. 5A), and copurification experiments found that RsmV interacts with RsmA and 
RsmF (Fig. 5B). Both of these findings suggest that RsmV can compete with RsmY and 
RsmZ for RsmA/RsmF binding in wt cells (Fig. 5B). Whether conditions exist where rsmV 
transcription is elevated and might result in more-pronounced phenotypes is unclear. 
Transcription of rsmY and rsmZ is directly controlled by the GacA/S two-component 
system, a highly conserved system in Gammaproteobacteria (24, 31, 32). GacS is a sensor 
kinase whose activity is controlled by two orphan kinases, RetS and LadS (33–36). 
Additional regulators interact with and alter the effect of RetS on GacS (37, 38). SuhB 
regulates rsmY and rsmZ transcription indirectly by altering gacA levels (39). The HptB 
phosphotransfer protein regulates rsmY and rsmZ transcription when P. aeruginosa is 
grown on a surface (40, 41). Other regulators contribute to rsmY and rsmZ transcription 
through mechanisms that do not alter GacS/GacA activity. MvaT, a H-NS like protein, 
binds AT-rich regions of DNA and silences rsmZ transcription, while BswR, a tran-
scriptional regulator, counteracts negative regulation of rsmZ by MvaT (24, 42). Re-
cently, MgtE, a magnesium transporter, was shown to alter rsmY and rsmZ transcription, 
though a mechanism of action is yet to be defined (43).
Neither rsmV nor rsmW is under positive transcriptional control of the GacAS system 
(23) (see Fig. S2 in the supplemental material). GacA may repress rsmW transcription 
through an indirect mechanism (30). RsmW expression appears to be highest during 
the stationary phase in minimal media, which may be more biologically representative 
of a biofilm (23). RsmW is encoded directly downstream of PA4570, a protein of 
unknown function. RsmW and PA4570 are likely cotranscribed and separated by an 
RNase cleavage event. Determining the transcriptional regulation of PA4570 may 
provide insight into rsmW transcriptional control. A search for potential promoters 
upstream of rsmV predicted binding sites for the transcriptional activators RhlR, AlgU, 
and FleQ. mRNA levels for rsmV, however, were unaffected in PA14 transposon mutants 
within each of those genes relative to the wild-type results as measured by qRT-PCR
(data not shown). Additional studies are required to determine how rsmV and rsmW
transcription is controlled and if RsmV plays a larger role in regulating RsmA and/or
RsmF activity under a different set of growth conditions.
RsmX, RsmY, and RsmZ in P. protogens are differentially expressed, thus contributing to
a mechanism of fine-tuning RsmA and RsmE activity (25). Expression of P. protogens RsmX
and expression of RsmY occur in parallel during exponential growth, while RsmZ expression
is delayed (25). This may allow cells to fine-tune expression of these sRNAs based on the
environmental conditions. We propose a similar scenario for expression of RsmV, RsmW,
RsmY, and RsmZ in P. aeruginosa. The differences in binding affinities for RsmA/RsmF,
timing of gene expression, and expression levels of the sRNAs may provide a mechanism
for fine-tuning the expression of genes under the control of the Rsm system.
MATERIALS AND METHODS
Strain and plasmid construction. The strains and plasmids used in the study are listed in Table S1 
in the supplemental material. Routine cloning was performed with E. coli DH5 cultured in LB-Lennox 
medium with gentamicin (15 g/ml) as required. P. aeruginosa strain PA103 and the gacA and rsmYZ 
mutants were reported previously (Table 1) (10, 14, 44, 45). The in-frame rsmV deletion mutant was 
constructed by allelic exchange. The upstream and downstream flanking regions (800 bp) of rsmV were 
generated by PCR using primer pair 118845409 and 118845410 and primer pair 118845411 and 
118845412. The PCR products were cloned into pEXG2 (46), and the resulting construct was mobilized 
into wild-type PA103 and the rsmYZ, rsmAYZ, and rsmFYZ mutants by conjugation. Merodiploids 
were resolved by sucrose counterselection as previously described (47). The RsmV expression plasmid 
was constructed by positioning the rsmV transcription start site immediately downstream of the PBAD 
promoter start site using the Gibson assembly method (New England Biolabs). Briefly, the PBAD promoter 
regions from pJN105 (primer pair 117830775 and 117830776) and rsmV (primer pair 118845423 and 
118845424) were amplified by PCR and then assembled into the MluI- and SacI-digested pJN105 plasmid 
(48). pRsmV vectors bearing single GGA-to-CCT substitutions, or various combinations thereof, were 
assembled using the Gibson method from gene blocks listed in Table S2 and cloned into the NruI and 
PvuI sites of pJN105 as outlined in Table S3. The rsmV transcriptional reporter (primer pair 150592489 and 
150592490) includes 500 nucleotides upstream of the rsmV transcription start site. The rsmV reporter was 
integrated into the CTX phage attachment site in wt and gacA strains.
-Galactosidase assays. PA103 strains were grown overnight at 37°C in LB containing 80 g/ml 
gentamicin as required. The next day, strains were diluted to an absorbance (A600) of 0.1 in tryptic soy broth 
(TSB) for measurement of tssA1=-=lacZ reporter activity or TSB supplemented with 100 mM monosodium 
glutamate and with 1% glycerol for measurement of PexsD-lacZ reporter activity. Arabinose (0.4%) was also 
added to induce rsmV expression from the PBAD promoter. The cultures were incubated at 37°C and harvested 
when the A600 reached 1.0. -Galactosidase activity was assayed with ortho-nitrophenyl-galactopyranoside 
(ONPG) substrate as previously described (49) or with chlorophenol red--D-galactopyranoside (CPRG) sub-
strate. CPRG activity was determined by measuring product formation at 578 nM and using an adaptation of 
the Miller equation as follows: CPRG units  (A578/culture A600/time/culture volume [in milliliters]) 1,000. 
CPRG and Miller unit values are reported as averages of results from at least three independent experiments, 
with error bars representing standard deviations (SD).
Electrophoretic mobility shift assays. DNA templates harboring wild-type rsmV or rsmV bearing point 
mutations within the GGA sequences were PCR amplified and used as templates for in vitro generation of RNA 
probes. RNA probes were end labeled with [-32P]ATP as previously described (10). Histidine-tagged RsmA 
and RsmF were purified by Ni2 affinity chromatography as described previously (10). RsmA or RsmF was 
incubated with the RNA probes at the indicated concentrations in 1 binding buffer (10 mM Tris-HCl [pH 7.5], 
10 mM MgCl2, 100 mM KCl), 3.25 ng/l total yeast tRNA (Life Technologies), 10 mM dithiothreitol (DTT), 5%
(vol/vol) glycerol, and 0.1 unit RNase Out (Life Technologies). Reaction mixtures were incubated at 37°C for 30 
min and then mixed with 2 l of gel loading buffer II (Life Technologies) and immediately subjected to 
electrophoresis on 7.5% (wt/vol) native polyacrylamide glycine gels (10 mM Tris-HCl [pH 7.5], 380 mM glycine, 
1 mM EDTA) at 4°C. Imaging was performed using an FLA-7000 phosphorimager (Fujifilm) and analyzed using 
MultiGuage v3.0 software. Binding properties were determined with Prism 6.0e using the binding saturation 
equation for specific binding. The apparent Keq represents the molar concentration of RsmA/RsmF required 
to shift 50% of the RNA probe. The apparent Keq values reported in the text are averages of results from at 
least three independent experiments.
qRT-PCR. Steady-state levels of native RsmV and the GGA mutants were determined by quantitative 
reverse transcription-PCR (qRT-PCR). Using SYBR green as previously described (37). cDNA was generated 
with an rsmV-specific primer (138770592) (Table S2) in reaction mixtures containing 100 ng of RNA, 9 l 
RNase-free water, 1 l oligonucleotide mix (2 pmol/l of specific primer), and 1 l deoxynucleoside 
triphosphate (dNTP) (10 mM) mix. Reaction mixtures were heated at 65°C for 5 min and then placed on 
ice for 1 min. A 4-l volume of 5 first-strand buffer, 1 l of 0.1 m DTT, 1 U of RNase Out, and 1 l of  
Superscript III reverse transcriptase (Life Technologies, Grand Island, NY) were added to each reaction 
mixture, and the mixture was incubated at 50°C for 1 h. Each reaction mixture was heat inactivated at 
70°C for 15 min. cDNA (2 ng) and 1.8 l of forward and reverse primers (primers 138770593 and 
138770594, respectively) (Table S2) were then added to Power SYBR green PCR master mix (Life
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Time course experiments measuring RsmV, RsmW, RsmY, and RsmZ levels were performed by 
qRT-PCR using TaqMan as previously described (50). cDNA (2 l) prepared as described above was added 
to reaction mixtures containing 10 l 2  TaqMan universal PCR master mix (Life Technologies, Grand 
Island, NY), 2 l of a gene-specific probe set (rimM, 126317493; rsmW, 149204991; rsmX, 149204995; rsmY, 
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RNA enrichment experiments. Strain PA14 ΔrsmAF carrying an empty vector control, pRsmAHis6, or  
pRsmFHis6 was grown in TSB supplemented with 20 mM MgCl2, 5 mM EGTA, 15 g/ml gentamicin, and 
0.1% arabinose to mid-log phase, chilled, and pelleted for immediate lysis. Cells were lysed under native 
conditions to retain protein structure (Qiagen QIAexpressionist manual native purification buffer recipe) 
using supplementation with 2.5 mM vanadyl ribonucleoside complex (NEB) (to inhibit RNase activity), 1 
mg/ml lysozyme, and 0.1% Triton X-100. Lysis was completed by freeze-thaw cycles. Lysates were treated 
with 10 l RQ-1 RNase-free DNase and cleared by centrifugation. An aliquot was removed from the 
cleared lysate for total RNA isolation and preserved in TRIzol, and the remaining lysate was incubated 
with nickel-nitrilotriacetic acid (Ni-NTA)–agarose at 4°C for 1 h under nondenaturing binding conditions. 
Ni-NTA–agarose was then loaded into a column and washed 3 times with nondenaturing binding buffer 
containing 10 mM imidazole. Protein and associated RNAs were eluted in 4 fractions with 250 mM 
imidazole and 4 fractions with 500 mM imidazole. Protein-containing fractions from the RsmAHis6- or  
RsmFHis6-expressing strains and an equivalent volume from the vector control strain were treated with 
TRIzol (Thermo Fisher), and RNA was extracted according to the manufacturer’s protocol. RNA was 
treated with RQ-1 RNase-free DNase and concentrated using a RNA Clean and Concentrator kit (Zymo). 
First-strand cDNA was synthesized using Superscript II (Thermo Fisher) according to the manufacturer’s 
protocol with Random Primer 9 (NEB). The copy number of the indicated genes was determined by qPCR 
using SYBR green master mix (Bio-Rad).
Statistical analyses. One-way analysis of variance (ANOVA) was performed using Prism 6.0 (Graph-
Pad Software, Inc., La Jolla, CA).
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